logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

Dual anti-HER2 therapy shows promise in esophageal adenocarcinoma

Preclinical studies as well as studies in breast cancer suggest that dual HER2 therapy might improve outcomes.